Cagrilintide 5mg

Description

Cagrilintide is a long-acting acylated amylin analog peptide that has emerged as a significant research compound in the study of metabolic signaling pathways. Structurally engineered through lipidation and amino acid substitution, cagrilintide exhibits an extended pharmacokinetic profile in preclinical models compared to native amylin, making it a valuable tool for researchers investigating sustained receptor activation dynamics and the pharmacology of long-acting peptide ligands. The unique fatty acid side chain promotes albumin binding, providing an informative model for studying peptide half-life extension strategies.

In laboratory investigations, this peptide has been utilized to study amylin receptor signaling, which involves the calcitonin receptor complexed with receptor activity-modifying proteins (RAMPs). Researchers exploring appetite regulation pathways, gastric motility signaling, and glucose homeostasis mechanisms in cell-based assay systems have employed cagrilintide as both a reference compound and an experimental reagent. In vitro receptor binding assays have characterized the affinity and selectivity profile of cagrilintide across amylin receptor subtypes, contributing to the broader understanding of the calcitonin receptor family and its downstream signaling through cAMP-dependent pathways.

Each vial of cagrilintide from PEPTEX Labs is supplied in lyophilized form and has been tested for purity, sequence confirmation, and peptide content. This product is intended strictly for use in scientific research applications. It is not suitable for human consumption or any therapeutic purpose.